TrademarkDir
PROBUPHINE
DEAD

Serial Number

86356901

Owner

TITAN PHARMACEUTICALS, INC.

Attorney

Muzamil Huq

First Use Date

Jun 10, 2016

Filing Date

Aug 4, 2014

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PROBUPHINE Trademark

Serial Number: 86356901 • Registration: 5171923

PROBUPHINE is a trademark filed by TITAN PHARMACEUTICALS, INC. on August 4, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

TITAN PHARMACEUTICALS, INC. (37 trademarks)

400 OYSTER POINT BOULEVARD-SUITE 505
SOUTH SAN FRANCISCO, CA 94080

Entity Type: 03

Trademark Details

Filing Date

August 4, 2014

Registration Date

March 28, 2017

First Use Anywhere

June 10, 2016

First Use in Commerce

June 10, 2016

Published for Opposition

December 9, 2014

Cancellation Date

October 13, 2023

Goods & Services

Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of pain management

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 12, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 12, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 12, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 12, 2024 COAR
CANCELLED SEC. 8 (6-YR)
Oct 13, 2023 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 28, 2022 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 26, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 26, 2018 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 28, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 21, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 19, 2017 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 8, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 8, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 13, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 13, 2017 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 30, 2016 GNRN
NON-FINAL ACTION E-MAILED
Aug 30, 2016 GNRT
SU - NON-FINAL ACTION - WRITTEN
Aug 30, 2016 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Aug 13, 2016 SUPC
USE AMENDMENT FILED
Jul 22, 2016 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 22, 2016 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 9, 2016 EXRA
SOU EXTENSION 2 GRANTED
Mar 8, 2016 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 7, 2016 AITU
SOU EXTENSION 2 FILED
Feb 3, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 3, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 31, 2015 EXRA
SOU EXTENSION 1 GRANTED
Jul 29, 2015 EX1G
SOU EXTENSION 1 FILED
Jul 29, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 29, 2015 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 3, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2014 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 1, 2014 PREV
ASSIGNED TO LIE
Oct 31, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 15, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 14, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 24, 2014 GNRN
NON-FINAL ACTION E-MAILED
Sep 24, 2014 GNRT
NON-FINAL ACTION WRITTEN
Sep 24, 2014 CNRT
ASSIGNED TO EXAMINER
Sep 23, 2014 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 13, 2014 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2014 NWOS
NEW APPLICATION ENTERED
Aug 7, 2014 NWAP

Related Trademarks

More from this Owner

BUPEPLANT

BUPEPLANT

BUPEPLANT

BUPEPLANT

STEP INTO STABILITY

STEP INTO STABILITY

STEP INTO STABILITY

STEP INTO STABILITY

TITAN PHARMACEUTICALS

TITAN PHARMACEUTICALS

TITAN PHARMACEUTICALS

TITAN PHARMACEUTICALS